EUVIMEDEUVIMED entdecken
Kohortenstudie

Plasma profiles of inflammatory cytokines in children with moderate to severe traumatic brain injury: a prospective cohort study

Haixin Huang, Guo Fu, Siwei Lu, Song Chen, Junming Huo, Yunni Ran, Changxue Xiao, Jian Chen, Dandan Pi, Fang Zhou, Hongxing Dang, Chengjun Liu und 1 weitere

European Journal of Pediatrics · 2024

DOI: 10.1007/s00431-024-05604-5 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Haixin Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China. Hauptthemen laut MEDLINE: Cytokines, Brain Injuries, Traumatic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Program for Youth Innovation in Future Medicine from Chongqing Medical University: Basic and Clinical Study of Critical Illness in Children, The Natural Science Foundation Project of Chongqing of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of inflammatory cytokines in children with moderate to severe TBI (m-sTBI) is still incompletely understood. We aimed to investigate the associations between early plasma expression profiles of inflammatory cytokines and clinical outcomes in children with m-sTBI. We prospectively recruited children admitted to the intensive care unit (ICU) of a tertiary pediatric hospital due to m-sTBI from November 2022 to May 2023. Plasma interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17A, interferon (IFN)-α, IFN-γ and tumor necrosis factor (TNF)-α concentrations were detected by flow cytometry on admission and on days 5 to 7. The primary outcome was in-hospital mortality. The secondary outcome was the 6-month functional outcome assessed by the Glasgow Outcome Scale Extended-Pediatrics (GOS-E Peds) score, dichotomized as favorable (1-4) or unfavorable (5-8). Fifty patients and 20 healthy controls were enrolled. Baseline IL-6, IL-8 and IL-10 levels were significantly higher in TBI patients than in healthy controls. Twelve patients died in the hospital. Compared with survivors, nonsurvivors had significantly increased baseline IL-6 and IL-8 levels. Baseline IL-5, IL-6 and IL-8 levels were also significantly greater in children with unfavorable versus favorable outcomes. The area under the receiver operating characteristic curve (AUC) of the IL-6 and IL-8 levels and motor Glasgow Coma Scale (GCS) score for predicting in-hospital mortality was 0.706, 0.754, and 0.776, respectively. Baseline IL-1β, IL-2, IL-4, IL-10, IL-12p70, IL-17A, IFN-γ, IFN-α and TNF-α levels were not associated with in-hospital mortality or an unfavorable 6-month outcome. On days 5 to 7, the IL-6 and IL-8 levels were significantly decreased in survivors but increased in nonsurvivors compared to their respective baselines. CONCLUSION: After m-sTBI, the plasma profiles of inflammatory cytokines are markedly altered in children. The trends of IL-6 and IL-8 expression vary among m-sTBI children with different outcomes. Elevated plasma IL-6 and IL-8 levels are related to in-hospital mortality and unfavorable 6-month outcomes. TRIAL REGISTRATION: This trial was registered in the Chinese Clinical Trial Registry (Registration number: ChiCTR2200065505). Registered November 7, 2022. WHAT IS KNOWN: • Inflammation is an important secondary physiological response to TBI. WHAT IS NEW: • The plasma profiles of inflammatory cytokines are markedly altered in children with m-sTBI. Elevated IL-6 and IL-8 levels are related to mortality and unfavorable outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesBrain Injuries, TraumaticHumansMaleFemaleProspective StudiesChildChild, PreschoolBiomarkersHospital MortalityCase-Control StudiesAdolescentPrognosisInfantGlasgow Outcome Scale

Stichwörter der Autor:innen

CytokinesInflammationMortalityTraumatic brain injury

Substanzen

CytokinesBiomarkers

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.
  • National Clinical Research Center for Child Health and Disorders, Chongqing, 400014, China.
  • Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, 400014, China.
  • Center for Clinical Molecular Medicine, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.
  • Department of Critical Care Medicine, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China. 480887@hospital.cqmu.edu.cn.
  • National Clinical Research Center for Child Health and Disorders, Chongqing, 400014, China. 480887@hospital.cqmu.edu.cn.

Förderung

  • Program for Youth Innovation in Future Medicine from Chongqing Medical University: Basic and Clinical Study of Critical Illness in Children
  • The Natural Science Foundation Project of Chongqing of China

Zitieren

APA

Huang, H., Fu, G., Lu, S., Chen, S., Huo, J., Ran, Y., Xiao, C., Chen, J., Pi, D., Zhou, F., Dang, H., Liu, C., & Fu, Y. Q. (2024). Plasma profiles of inflammatory cytokines in children with moderate to severe traumatic brain injury: a prospective cohort study. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05604-5

Vancouver

Huang H, Fu G, Lu S, Chen S, Huo J, Ran Y, et al. Plasma profiles of inflammatory cytokines in children with moderate to severe traumatic brain injury: a prospective cohort study. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05604-5

BibTeX
@article{Huang2024,
  author = {Huang, Haixin and Fu, Guo and Lu, Siwei and Chen, Song and Huo, Junming and Ran, Yunni and Xiao, Changxue and Chen, Jian and Pi, Dandan and Zhou, Fang and Dang, Hongxing and Liu, Chengjun and Fu, Yue-Qiang},
  title = {Plasma profiles of inflammatory cytokines in children with moderate to severe traumatic brain injury: a prospective cohort study},
  journal = {European Journal of Pediatrics},
  year = {2024},
  doi = {10.1007/s00431-024-05604-5}
}
Kostenlos starten →